US Generic Injectables Market Analysis, Top Companies, New Technology, Demand and Opportunity
The latest report by IMARC Group, titled “ US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023 ”, finds that the US generic injectables market reached a value of US$ 10.7 Billion in 2017, growing at a CAGR of more than 9% during 2010-2017. Generic injectables are used as an alternative to innovator injectables without compromising the effectiveness of the treatment. They are available in the market only after the expiry of the innovator injectables. Generic injectables are extensively used for treating numerous life-threatening and chronic diseases such as cardiovascular diseases, respiratory diseases, diabetes, rheumatoid arthritis, cancer, osteoporosis and osteoarthritis. They are less expensive than their branded counterparts, thereby contributing in substantial savings for the patients and healthcare providers. Request to get the sample report: https://www.imarcgroup.com/us-generic-injectables-market/req...